Clearbridge Health (1H3.SI) Stock Price

Clearbridge Health Price

CLOSED
0.00SGD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 46.7% per year over the past 10 years to 9.90 M SGD. Earnings per share have declined at 33.7% per year over the last 6 years. Clearbridge Health's net margin stands at -36.4%, down from 1.7% several years earlier.

Clearbridge Health stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Clearbridge Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Clearbridge Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Clearbridge Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Clearbridge Health Stock Price History
DateClearbridge Health Price
7/17/20260.00 SGD
7/16/20260.00 SGD
7/15/20260.00 SGD
7/14/20260.00 SGD
7/13/20260.00 SGD
7/10/20260.00 SGD
7/9/20260.00 SGD
7/8/20260.00 SGD
7/7/20260.00 SGD
7/6/20260.00 SGD
7/3/20260.00 SGD
7/2/20260.00 SGD
7/1/20260.00 SGD
6/30/20260.00 SGD
6/29/20260.00 SGD
6/26/20260.00 SGD
6/25/20260.00 SGD
6/24/20260.00 SGD
6/23/20260.00 SGD
6/22/20260.00 SGD
6/19/20260.00 SGD
6/18/20260.00 SGD
6/17/20260.00 SGD
6/16/20260.00 SGD
6/15/20260.00 SGD
6/12/20260.00 SGD
6/11/20260.00 SGD
6/10/20260.00 SGD
6/9/20260.00 SGD
6/8/20260.00 SGD
6/5/20260.00 SGD
6/4/20260.00 SGD
6/3/20260.00 SGD
6/2/20260.00 SGD
5/29/20260.00 SGD
5/28/20260.00 SGD
5/27/20260.00 SGD
5/26/20260.00 SGD
5/25/20260.00 SGD
5/22/20260.00 SGD
5/21/20260.00 SGD
5/20/20260.00 SGD
5/19/20260.00 SGD
5/18/20260.00 SGD
5/15/20260.00 SGD
5/14/20260.00 SGD
5/13/20260.00 SGD
5/12/20260.00 SGD
5/11/20260.00 SGD
5/8/20260.00 SGD
5/7/20260.00 SGD
5/6/20260.00 SGD
5/5/20260.00 SGD
5/4/20260.00 SGD
5/1/20260.00 SGD
4/30/20260.00 SGD
4/29/20260.00 SGD
4/28/20260.00 SGD
4/27/20260.00 SGD
4/24/20260.00 SGD
4/23/20260.00 SGD
4/22/20260.00 SGD
4/21/20260.00 SGD
4/20/20260.00 SGD
4/17/20260.00 SGD
4/16/20260.00 SGD
4/15/20260.00 SGD
4/14/20260.00 SGD
4/13/20260.00 SGD
4/10/20260.00 SGD
4/9/20260.00 SGD
4/8/20260.00 SGD
4/7/20260.00 SGD
4/6/20260.00 SGD
4/2/20260.00 SGD
4/1/20260.00 SGD
3/31/20260.00 SGD
3/30/20260.00 SGD
3/27/20260.00 SGD
3/26/20260.00 SGD
3/25/20260.00 SGD
3/24/20260.00 SGD
3/23/20260.00 SGD
3/20/20260.00 SGD
3/19/20260.00 SGD
3/18/20260.00 SGD
3/17/20260.00 SGD
3/16/20260.00 SGD
3/13/20260.00 SGD
3/12/20260.00 SGD
3/11/20260.00 SGD
3/10/20260.00 SGD
3/9/20260.00 SGD
3/6/20260.00 SGD
3/5/20260.00 SGD
3/4/20260.00 SGD
3/3/20260.00 SGD
3/2/20260.00 SGD
2/27/20260.00 SGD
2/26/20260.00 SGD
2/25/20260.00 SGD
2/24/20260.00 SGD
2/23/20260.00 SGD
2/20/20260.00 SGD
2/19/20260.00 SGD
2/16/20260.00 SGD
2/13/20260.00 SGD
2/12/20260.00 SGD
2/11/20260.00 SGD
2/10/20260.00 SGD
2/9/20260.00 SGD
2/6/20260.00 SGD
2/5/20260.00 SGD
2/4/20260.00 SGD
2/3/20260.00 SGD
2/2/20260.00 SGD
1/30/20260.00 SGD
1/29/20260.00 SGD
1/28/20260.00 SGD
1/27/20260.00 SGD
1/26/20260.00 SGD
1/23/20260.00 SGD
1/22/20260.00 SGD
1/21/20260.00 SGD
1/20/20260.00 SGD
1/19/20260.00 SGD
1/16/20260.00 SGD
1/15/20260.00 SGD
1/14/20260.00 SGD
1/13/20260.00 SGD
1/12/20260.00 SGD
1/9/20260.00 SGD
1/8/20260.00 SGD
1/7/20260.00 SGD
1/6/20260.00 SGD
1/5/20260.00 SGD
1/2/20260.00 SGD
12/31/20250.00 SGD
12/30/20250.00 SGD
12/29/20250.00 SGD
12/26/20250.00 SGD
12/24/20250.00 SGD
12/23/20250.00 SGD
12/22/20250.00 SGD
12/19/20250.00 SGD
12/18/20250.00 SGD
12/17/20250.00 SGD
12/16/20250.00 SGD
12/15/20250.00 SGD
12/12/20250.00 SGD
12/11/20250.00 SGD
12/10/20250.00 SGD
12/9/20250.00 SGD
12/8/20250.00 SGD
12/5/20250.00 SGD
12/4/20250.00 SGD
12/3/20250.00 SGD
12/2/20250.00 SGD
12/1/20250.00 SGD
11/28/20250.00 SGD
11/27/20250.00 SGD
11/26/20250.00 SGD
11/25/20250.00 SGD
11/24/20250.00 SGD
11/21/20250.00 SGD
11/20/20250.00 SGD
11/19/20250.00 SGD
11/18/20250.00 SGD
11/17/20250.00 SGD
11/14/20250.00 SGD
11/13/20250.00 SGD
11/12/20250.00 SGD
11/11/20250.00 SGD
11/10/20250.00 SGD
11/7/20250.00 SGD
11/6/20250.00 SGD
11/5/20250.00 SGD
11/4/20250.00 SGD
11/3/20250.00 SGD
10/31/20250.00 SGD
10/30/20250.00 SGD
10/29/20250.00 SGD
10/28/20250.00 SGD
10/27/20250.00 SGD
10/24/20250.00 SGD
10/23/20250.00 SGD
10/22/20250.00 SGD
10/21/20250.00 SGD
10/17/20250.00 SGD
10/16/20250.00 SGD
10/15/20250.00 SGD
10/14/20250.00 SGD
10/13/20250.00 SGD
10/10/20250.00 SGD
10/9/20250.00 SGD
10/8/20250.00 SGD
10/7/20250.00 SGD
10/6/20250.00 SGD
10/3/20250.00 SGD
10/2/20250.00 SGD
10/1/20250.00 SGD
9/30/20250.00 SGD
9/29/20250.00 SGD
9/26/20250.00 SGD
9/25/20250.00 SGD
9/24/20250.00 SGD
9/23/20250.00 SGD
9/22/20250.00 SGD
9/19/20250.00 SGD
9/18/20250.00 SGD
9/17/20250.00 SGD
9/16/20250.00 SGD
9/15/20250.00 SGD
9/12/20250.00 SGD
9/11/20250.00 SGD
9/10/20250.00 SGD
9/9/20250.00 SGD
9/8/20250.00 SGD
9/5/20250.00 SGD
9/4/20250.00 SGD
9/3/20250.00 SGD
9/2/20250.00 SGD
9/1/20250.00 SGD
8/29/20250.00 SGD
8/28/20250.00 SGD
8/27/20250.00 SGD
8/26/20250.00 SGD
8/25/20250.00 SGD
8/22/20250.00 SGD
8/21/20250.00 SGD
8/20/20250.00 SGD
8/19/20250.00 SGD
8/18/20250.00 SGD
8/15/20250.00 SGD
8/14/20250.00 SGD
8/13/20250.00 SGD
8/12/20250.00 SGD
8/11/20250.00 SGD
8/8/20250.00 SGD
8/7/20250.00 SGD
8/6/20250.00 SGD
8/5/20250.00 SGD
8/4/20250.00 SGD
8/1/20250.00 SGD
7/31/20250.00 SGD
7/30/20250.00 SGD
7/29/20250.00 SGD
7/28/20250.00 SGD
7/25/20250.00 SGD
7/24/20250.00 SGD
7/23/20250.00 SGD
Access this data via the Eulerpool API
Get Free API Key

Clearbridge Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
288,000.00 SGD
-8.59 M SGD
-7.47 M SGD
Jan 1, 2018
6.14 M SGD
-8.87 M SGD
-18.45 M SGD
Jan 1, 2019
21.53 M SGD
-8.09 M SGD
-10.59 M SGD
Jan 1, 2020
36.26 M SGD
-1.28 M SGD
615,000.00 SGD
Jan 1, 2021
11.44 M SGD
-4.76 M SGD
-19.97 M SGD
Jan 1, 2022
16.41 M SGD
-1.27 M SGD
-11.14 M SGD
Jan 1, 2023
10.41 M SGD
-13.53 M SGD
-32.20 M SGD
Jan 1, 2024
9.90 M SGD
-3.67 M SGD
-3.61 M SGD

Clearbridge Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 22, 2026, 3:54 PM
 
REVENUEM SGD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM SGD
EBITM SGD
EBIT MARGIN%
NET INCOMEM SGD
NET INCOME GROWTH%
SHARESB
20142015201620172018201920202021202220232024
––––6.0021.0036.0011.0016.0010.009.00
–––––250.0071.43-69.4445.45-37.50-10.00
––––33.3333.3336.1154.5556.2550.0044.44
4.004.004.004.002.007.0013.006.009.005.004.00
-2.00-3.00-6.00-8.00-8.00-8.00-1.00-4.00-1.00-13.00-3.00
––––-133.33-38.10-2.78-36.36-6.25-130.00-33.33
4.004.00-1.00-7.00-18.00-10.00–-19.00-11.00-32.00-3.00
––-125.00600.00157.14-44.44––-42.11190.91-90.63
0.390.390.390.320.490.520.601.111.111.111.24
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Clearbridge Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Clearbridge Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Clearbridge Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Clearbridge Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Clearbridge Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Clearbridge Health stock margins

The Clearbridge Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Clearbridge Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Clearbridge Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
16.32 %
-2,981.60 %
-2,593.75 %
Jan 1, 2018
47.03 %
-144.55 %
-300.70 %
Jan 1, 2019
33.25 %
-37.55 %
-49.16 %
Jan 1, 2020
38.10 %
-3.53 %
1.70 %
Jan 1, 2021
55.61 %
-41.57 %
-174.53 %
Jan 1, 2022
58.35 %
-7.71 %
-67.90 %
Jan 1, 2023
49.26 %
-130.00 %
-309.40 %
Jan 1, 2024
48.26 %
-37.08 %
-36.43 %

Clearbridge Health Stock Revenue, EBIT, Earnings per Share

The Clearbridge Health earnings per share therefore indicates how much revenue Clearbridge Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.00 SGD
-0.03 SGD
-0.02 SGD
Jan 1, 2018
0.01 SGD
-0.02 SGD
-0.04 SGD
Jan 1, 2019
0.04 SGD
-0.02 SGD
-0.02 SGD
Jan 1, 2020
0.06 SGD
-0.00 SGD
0.00 SGD
Jan 1, 2021
0.01 SGD
-0.00 SGD
-0.02 SGD
Jan 1, 2022
0.01 SGD
-0.00 SGD
-0.01 SGD
Jan 1, 2023
0.01 SGD
-0.01 SGD
-0.03 SGD
Jan 1, 2024
0.01 SGD
-0.00 SGD
-0.00 SGD

Clearbridge Health business model & stock analysis

Clearbridge Health Ltd is an international company in the healthcare and diagnostics sector based in Singapore. The company was founded in 2017 and focuses on the use of innovative technology, information, and communication systems to provide efficient and precise diagnostics and medical care. The business model of Clearbridge Health is based on a wide range of services and products, divided into three segments: Clinical diagnostics, healthcare services, and digitization. These divisions are interconnected and allow the company to offer a comprehensive range of healthcare services. In the field of clinical diagnostics, the company offers a variety of laboratory and radiology services. Clearbridge Health has a strong presence in Singapore and Indonesia, where it has several diagnostic laboratories specializing in areas such as pathology, microbiology, genetics, and molecular diagnostics. In addition, the company has partnerships with leading diagnostic laboratories worldwide to provide its customers with an even broader range of diagnostic options. In the healthcare services segment, Clearbridge Health offers a wide range of services including diagnosis, treatment, and disease prevention, as well as health management. A key focus in this area is the care of cancer patients. Here, the company has developed a unique self-financing model where it invests in diagnosis and treatment and benefits from the outcomes achieved. The goal is to provide cancer patients with fast diagnosis and comprehensive, personalized treatment. Clearbridge Health has partnerships with leading cancer centers worldwide and utilizes the latest technologies to enable fast and accurate diagnosis. In the digitization segment, Clearbridge Health offers innovative technology solutions to digitalize the healthcare sector and improve efficiency in healthcare delivery. One of the products includes a cloud-based platform for medical imaging called teleradiology. The platform allows for the digital transmission of images from one location to another, saving time and costs and improving efficiency in patient diagnosis and treatment. Clearbridge Health has experienced rapid growth in recent years. The company has expanded its presence in Asia and other parts of the world and continues to pursue an ambitious expansion strategy. The goal is to become a global leader in healthcare and diagnostics. In summary, Clearbridge Health is an innovative company in the healthcare and diagnostics sector that offers a wide range of services and products. The company has a strong presence in Asia and collaborates closely with leading diagnostic laboratories and cancer centers worldwide. Clearbridge Health is committed to improving healthcare delivery and promoting the adoption of innovative technology solutions to enhance efficiency. The company has experienced impressive growth in recent years and continues to pursue an ambitious expansion strategy.

Clearbridge Health SWOT Analysis

Strengths

Clearbridge Health Ltd has several key strengths that contribute to its competitive advantage in the market. Firstly, the company has built a strong network of strategic partnerships with leading healthcare providers, enabling it to expand its reach and access a wider customer base. This extensive network allows Clearbridge Health Ltd to offer comprehensive healthcare solutions and deliver quality services to its clients.

Another strength of Clearbridge Health Ltd is its focus on cutting-edge technology and innovation. The company leverages advanced medical technologies, such as genetic testing and precision medicine, to deliver personalized healthcare solutions. This technological expertise gives Clearbridge Health Ltd a competitive edge in the industry, attracting customers seeking state-of-the-art healthcare services.

Additionally, Clearbridge Health Ltd has a team of highly skilled and experienced professionals. The company's committed and knowledgeable workforce is well-equipped to provide expert medical advice and deliver superior patient care. This expertise enhances the company's reputation and builds trust with customers, positioning Clearbridge Health Ltd as a leading player in the healthcare sector.

Weaknesses

Despite its strengths, Clearbridge Health Ltd faces certain weaknesses that could potentially hinder its growth and competitiveness. One weakness is the company's relatively limited geographical presence. Clearbridge Health Ltd predominantly operates within specific regions, which may limit its market share and growth opportunities compared to larger competitors with national or international reach.

Another weakness is the potential dependency on external suppliers or partners for certain medical technologies or services. This reliance on external entities can introduce risks of delays, increased costs, or quality control issues. Clearbridge Health Ltd must effectively manage these dependencies to ensure seamless operations and maintain customer satisfaction.

Opportunities

Several opportunities exist for Clearbridge Health Ltd to further expand its market presence and enhance its offerings. One opportunity arises from the growing demand for personalized healthcare solutions. As more individuals seek tailored medical treatments and preventive care, Clearbridge Health Ltd can capitalize on this trend by strengthening its expertise in genetic testing, precision medicine, and data analytics to provide highly customized healthcare services.

Additionally, Clearbridge Health Ltd can explore strategic partnerships with insurance providers or government agencies to increase accessibility to its services. Collaboration with insurers or government entities can result in broader coverage for patients, potentially driving higher patient volumes and revenue for the company.

Threats

Clearbridge Health Ltd faces certain threats that could impact its operations and market position. One significant threat is the intense competition in the healthcare industry. The presence of numerous established players and emerging startups increases the pressure on Clearbridge Health Ltd to continuously innovate and differentiate itself to attract and retain customers. Failure to stay ahead of competitors may result in a loss of market share.

Another threat comes from potential changes in healthcare regulations or policies. Shifts in regulatory frameworks can impact the reimbursement rates, licensing requirements, or operational practices, affecting the profitability and viability of Clearbridge Health Ltd's business model. The company must stay informed and adapt accordingly to navigate any regulatory challenges successfully.

Clearbridge Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Clearbridge Health historical P/E ratio, EBIT multiple, and P/S ratio

Clearbridge Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Clearbridge Health shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
320.38 M Stocks
Jan 1, 2018
487.13 M Stocks
Jan 1, 2019
522.07 M Stocks
Jan 1, 2020
600.63 M Stocks
Jan 1, 2021
1.11 B Stocks
Jan 1, 2022
1.11 B Stocks
Jan 1, 2023
1.11 B Stocks
Jan 1, 2024
1.24 B Stocks
Price targets and forecasts for Clearbridge Health are not yet available.

Clearbridge Health shareholder structure

% Name
49.13818%
Bonvests Holdings Ltd
Bonvests Holdings Ltd
19.75237%
Yee (Pinh Jeremy)
Yee (Pinh Jeremy)
18.97707%
Chen (Johnson)
Chen (Johnson)
10.33849%
Wong (Kong Leong)
Wong (Kong Leong)
6.74705%
Hoo (Kia Wei Simon)
Hoo (Kia Wei Simon)
2.56942%
Seow (Peck Tiang)
Seow (Peck Tiang)

Clearbridge Health Executives and Management Board

JC

Mr. Johnson Chen

(46)

Director, Founder · since 2021

AL

Andrew Lord

Director

HM

Mr. How Soon Mah

(49)

Director

MR

Mark Ryan

Director

JY

Mr. Jeremy Yee

(48)

Director

Frequently asked questions about Clearbridge Health

The business model of Clearbridge Health Ltd revolves around providing integrated healthcare services and medical technology solutions. Clearbridge Health aims to enhance medical outcomes and deliver personalized patient care through its network of clinics and diagnostic centers across Asia. The company focuses on precision medicine, leveraging advanced diagnostics, medical imaging, and innovative digital platforms to enable early disease detection, diagnosis, and treatment. By combining cutting-edge technology with a patient-centric approach, Clearbridge Health strives to improve healthcare accessibility and deliver sustainable growth in the rapidly evolving healthcare industry.

All fundamentals and in-depth analysis of Clearbridge Health

Our stock analysis for Clearbridge Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearbridge Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Clearbridge Health Stock
Clearbridge Health Revenue→
Clearbridge Health Stock
Clearbridge Health Net Income→
Clearbridge Health Stock
Clearbridge Health P/E→
Clearbridge Health Stock
Clearbridge Health P/S→
Clearbridge Health Stock
Clearbridge Health EBIT→
Clearbridge Health Stock
Clearbridge Health Dividend→
Clearbridge Health Stock
Clearbridge Health Directors Dealings→
Clearbridge Health Stock
Clearbridge Health Stocks→
Clearbridge Health Stock
Clearbridge Health Market capitalization→
Clearbridge Health Stock
Clearbridge Health Debt→
Clearbridge Health Stock
Clearbridge Health Liabilities→
Clearbridge Health Stock
Clearbridge Health Equity→
Clearbridge Health Stock
Clearbridge Health AAQS→
Clearbridge Health Stock
Clearbridge Health Employees→
Clearbridge Health Stock
Clearbridge Health ROE→
Clearbridge Health Stock
Clearbridge Health ROA→
Clearbridge Health Stock
Clearbridge Health ROCE→
Clearbridge Health Stock
Clearbridge Health News→
Clearbridge Health Stock
Clearbridge Health Analyst Price Targets→

Health Stocks

Clearmind MedicineCleanspace HoldingsClearpoint NeuroClassysClearside BiomedicalClarity PharmaceuticalsCleneClarity Medical Group HoldingCleopatra Hospital SAEClaritevClever Culture SystemsClarianeAll Stocks A–Z →